ArticleJournal of the American Heart Association2026
Location-Specific Hematoma Volume Tolerance for Spontaneous Intracerebral Hemorrhage: A Pooled Analysis of INTERACT2 and ATACH II.
Article in Journal of the American Heart Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association of Time of Day With Functional Outcome in Intracerebral Hemorrhage.European journal of neurology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLocation-specific hematoma-volume thresholds are potentially important for prognostication and surgical decisions in acute intracerebral hemorrhage. We aimed to define this metric in relation to poor functional outcome in a pooled individual patient-level data analysis of 2 large intracerebral hemorrhage clinical trials: ATACH II (Antihypertensive Treatment of Acute Cerebral Hemorrhage) and INTERACT2 (Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial).
methodsFinal hematoma volumes were measured using planimetric analysis of 24-hour computed tomography in relation to hematoma location stratified by basal ganglia, thalamus, and lobar regions. Volume thresholds in 5-mL increments to >50 mL and Youden's index were used to identify optimal thresholds associated with poor outcome (modified Rankin Scale scores, 4-6) and death at 3 months. Multivariable logistic regression was used to estimate adjusted odds ratio models within each location.
resultsThere were 1691 patients included in these analyses, with 919 (54.3%), 551 (32.6%), and 221 (13.1%) located in the basal ganglia, thalamus, and lobar regions, respectively. Using Youden's index, location-specific hematoma volume thresholds (mL) that were most predictive of poor outcome were: 22.24 for basal ganglia (sensitivity, 0.57; specificity, 0.84; adjusted odds ratio, 4.82 [95% CI, 3.19-7.27]), 8.13 for thalamus (sensitivity, 0.68; specificity, 0.75; adjusted odds ratio, 2.73 [95% CI, 1.62-4.59]), and 21.99 for lobar (sensitivity, 0.82; specificity, 0.64; adjusted odds ratio, 6.31 [95% CI, 2.53-15.74]). Hematoma volume thresholds predictive of death were 19.72 for basal ganglia, 10.06 for thalamic, and 51.94 for lobar intracerebral hemorrhage.
conclusionsHematoma volumes associated with poor outcomes and death vary by anatomic location, indicating that each brain region has a distinct volume tolerance. Location-specific volume thresholds may guide surgical intervention to reduce hematoma burden.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.